Table 5.
Summary of epistasis QTL for DS and VRI identified during the present study.
| Trait | QTL Name | Chr. | Flanking Markers | Interval | Position | Add Effect | p Value | AA*E | p Value | D | Location | Other Associated Trait |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DS (Type-II | QFhs.lrdc-2A | 2A | BOBWHITE_C24021_254-BS00022456_51 | 120.1–124.3 | 122.3 | 0.9 | 0.000630 | 1.8 | 0.000054 | U | B, O | PHT |
| Resistance) | QFhs.lrdc-3B | 3B | RAC875_C7158_687-BS00074688_51 | 99.4–106.6 | 103.9 | - | ||||||
| VRI | QFhb.lrdc-1A.2 | 1A | WSNP_BF474340A_TA_2_1-EXCALIBUR_REP_C77271_230 | 38.8–49.5 | 44.2 | 1.8 | 0.000013 | −1.4 | 0.026233 | U | B, O | - |
| QFhb.lrdc-3A.2 | 3A | RAC875_REP_C106170_204-WSNP_EX_C55096_57733894 | 175.9–194.3 | 184.5 | - |
Note: D: donor; T: TMP16315; U: AC Ultima; B: Beloeil; O: Ottawa.